Dr. Bassel Nazha, MD, MPH
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Skin Cancer
Studies Kidney Cancer
7 reported clinical trials
16 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
FH positive
2Kidney Cancer
Stage IV
Stage III
FH positive
Affiliated Hospitals
Clinical Trials Bassel Nazha, MD, MPH is currently running
Enfortumab Vedotin + Pembrolizumab
for Advanced Bladder Cancer
This phase II trial tests how well enfortumab vedotin (EV) and pembrolizumab works in treating patients with bladder cancer of variant histology (a group of less common types of bladder cancer) that have spread to nearby tissue or lymph nodes (locally advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). Enfortumab vedotin is a monoclonal antibody, enfortumab, linked to an anticancer drug called vedotin. Enfortumab attaches to a protein called nectin-4 on cancer cells in a targeted way and delivers vedotin to kill them. It is a type of antibody-drug conjugate. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving enfortumab vedotin and pembrolizumab may kill more tumor cells in patients with locally advanced or metastatic bladder cancer of variant histology.
Recruiting1 award Phase 216 criteria
Immune Checkpoint Inhibitors + Propranolol
for Bladder Cancer
This research study is an open label study designed to evaluate the safety and translational correlative changes of the combination of propranolol hydrochloride and immune checkpoint inhibitors (ICI) in subjects with urothelial carcinoma.
Recruiting1 award Phase 211 criteria
More about Bassel Nazha, MD, MPH
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Bassel Nazha, MD, MPH has experience with
- Pembrolizumab
- Atezolizumab
- Cabozantinib
- Propranolol Hydrochloride
- Enfortumab Vedotin
- Lenvatinib
Breakdown of trials Bassel Nazha, MD, MPH has run
Skin Cancer
Kidney Cancer
Urethral Cancer
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bassel Nazha, MD, MPH specialize in?
Bassel Nazha, MD, MPH focuses on Skin Cancer and Kidney Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Bassel Nazha, MD, MPH currently recruiting for clinical trials?
Yes, Bassel Nazha, MD, MPH is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Bassel Nazha, MD, MPH has studied deeply?
Yes, Bassel Nazha, MD, MPH has studied treatments such as Pembrolizumab, Atezolizumab, Cabozantinib.
What is the best way to schedule an appointment with Bassel Nazha, MD, MPH?
Apply for one of the trials that Bassel Nazha, MD, MPH is conducting.
What is the office address of Bassel Nazha, MD, MPH?
The office of Bassel Nazha, MD, MPH is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.